Across rheumatic diseases

Temporal trends in overall infection incidence in patients with inflammatory arthritides treated with tumour necrosis factor inhibitors: a nationwide cohort study

Clin Exp RheumatolPublished Matched cohort study

Main finding · SI, last vs first period (TNFi-treated)Result — go to the resultIncidence rate ratio 0.48 CI 0.25–0.94

Authors' conclusion

The study found that the IRR of serious infections associated with TNFi in patients with inflammatory arthritides has decreased over the years.

Study context

Population
Adult biologic-naive patients with RA, PsA and SpA initiating a tumour necrosis factor inhibitors (TNFi), ICEBIO registry; observed 2 years before and after TNFi initiation
Participants
1,387 vs 6,936
Exposure
TNFi-treated patients with inflammatory arthritides, last vs first period, and general population comparators
  • TNFin = 1,387
  • Comparatorsn = 6,936reference
Outcome
Temporal trends in incidence rate (IR) (per 1000 patient-years) and IRR of serious infections and antimicrobial prescriptions across four-year periods
Methodological detailsnationwide, matched on age, sex and calendar time to five general population comparators, ICEBIO registry, four-year periods
  • Nationwide
  • Matched on age, sex and calendar time to five general population comparators
  • ICEBIO registry
  • Four-year periods

Main finding

SI, last vs first period (TNFi-treated)

Incidence rate ratio

0.48

CI 0.25–0.94

P = 0.03

TNFi, last periodvs TNFi, first period
IRR 0.48 (CI 0.25–0.94); P = 0.03

As reported in the abstract

Observational data: associations, not effects.

Further findings

OutcomeIRR (CI)
Antimicrobial prescriptions, between-period IRR (last vs first period)Between-period IRR1.05 (0.93–1.2)

Comparators: Serious infections (SI) and antimicrobial prescriptions, between-period IRR

IRR (CI)
ComparatorsAntimicrobial prescriptions; between-period IRR1.2 (1.1–1.3)
IRR for comparators was stable for SI

Original publication

Temporal trends in overall infection incidence in patients with inflammatory arthritides treated with tumour necrosis factor inhibitors: a nationwide cohort study. Clin Exp Rheumatol. Published 10 December 2024. doi:10.55563/clinexprheumatol/ijo29l

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.